T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 2361543)

Published in Br J Cancer on July 25, 2005


J C Steele1, C H Mann, S Rookes, T Rollason, D Murphy, M G Freeth, P H Gallimore, S Roberts

Author Affiliations

1: Cancer Research UK Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. j.c.steele@bham.ac.uk

Articles citing this

CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend. Cancer Immunol Immunother (2011) 0.95

Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia. Clin Exp Immunol (2007) 0.95

Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(-) controls. Mediators Inflamm (2007) 0.92

Perceived stress is associated with impaired T-cell response to HPV16 in women with cervical dysplasia. Ann Behav Med (2008) 0.92

HPV infection: immunological aspects and their utility in future therapy. Infect Dis Obstet Gynecol (2013) 0.89

New Approaches to Immunotherapy for HPV Associated Cancers. Cancers (Basel) (2011) 0.89

Immunologic Control of Mus musculus Papillomavirus Type 1. PLoS Pathog (2015) 0.83

Increase of human papillomavirus-16 E7-specific T helper type 1 response in peripheral blood of cervical cancer patients after radiotherapy. Immunology (2008) 0.82

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases. Hum Vaccin Immunother (2016) 0.82

CD4+ T cells against human papillomavirus-18 E7 in patients with high-grade cervical lesions associate with the absence of the virus in the cervix. Immunology (2010) 0.81

T-cell response to human papillomavirus type 58 L1, E6, And E7 peptides in women with cleared infection, cervical intraepithelial neoplasia, or invasive cancer. Clin Vaccine Immunol (2010) 0.79

Human papillomavirus 16-specific T cell responses in classic HPV-related vulvar intra-epithelial neoplasia. Determination of strongly immunogenic regions from E6 and E7 proteins. Clin Exp Immunol (2009) 0.79

Substantial increase in the frequency of circulating CD4+NKG2D+ T cells in patients with cervical intraepithelial neoplasia grade 1. J Biomed Sci (2013) 0.77

Cancer prevention in HIV-infected populations. Semin Oncol (2015) 0.77

Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination. Cell Biosci (2015) 0.76

Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models. Cancer Immunol Immunother (2015) 0.76

Induction of CD4-independent E7-specific CD8+ memory response by heat shock fusion protein. Clin Vaccine Immunol (2007) 0.76

High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected women. Oncoimmunology (2016) 0.75

Detection of human papillomavirus type 16-specific T lymphocytes by a recombinant vaccinia virus-based enzyme-linked immunospot assay. Clin Vaccine Immunol (2007) 0.75

Recent advances in understanding and preventing human papillomavirus-related disease. F1000Res (2017) 0.75

An approach to the immunophenotypic features of circulating CD4⁺NKG2D⁺ T cells in invasive cervical carcinoma. J Biomed Sci (2015) 0.75

Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4(+) T Cells. Front Immunol (2017) 0.75

Dendritic cell function and pathogen-specific T cell immunity are inhibited in mice administered levonorgestrel prior to intranasal Chlamydia trachomatis infection. Sci Rep (2016) 0.75

CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer. Oncoimmunology (2017) 0.75

Articles cited by this

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86

Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med (1998) 11.61

Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet (2001) 7.31

Cancer statistics, 1998. CA Cancer J Clin (1998) 6.26

Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst (1999) 4.27

Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst (2000) 3.81

Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis (2000) 3.36

Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol (1991) 3.10

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet (1996) 2.59

Immunological events in regressing genital warts. Am J Clin Pathol (1994) 2.37

Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ (2003) 2.04

Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis (1995) 1.94

Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6. Cancer Res (2004) 1.90

Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16: relationship to cervical intraepithelial neoplasia. J Infect Dis (1997) 1.57

Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4. Virology (1997) 1.56

Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccination. Clin Cancer Res (2004) 1.51

Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens. J Infect Dis (2000) 1.50

Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter. Cancer Res (2003) 1.40

Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Res (1996) 1.39

Plane warts under spontaneous regression. Immunopathologic study on cellular constituents leading to the inflammatory reaction. Arch Dermatol (1986) 1.39

Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes. Cancer Res (1997) 1.29

Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes. Int J Cancer (2001) 1.25

Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects. Cancer Res (2002) 1.22

Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide. Cancer Epidemiol Biomarkers Prev (2002) 1.19

Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope. Cancer Res (1996) 1.18

Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens. Cancer Res (2000) 1.14

Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia. J Natl Cancer Inst (1997) 1.13

Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia. Clin Cancer Res (2003) 1.12

Global burden of cancer. Lancet (1997) 1.05

Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope. Am J Obstet Gynecol (1996) 1.05

Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study. Cancer Res (1998) 1.04

Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia. Int J Cancer (2000) 1.02

Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III. Cancer Res (1997) 0.99

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome. J Gen Virol (1999) 0.98

Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector. Cancer Gene Ther (2001) 0.98

Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7. Lancet (2000) 0.97

T-cell proliferative response to human papillomavirus type 16 peptides: relationship to cervical intraepithelial neoplasia. Clin Diagn Lab Immunol (1996) 0.96

Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia. J Gen Virol (1999) 0.94

Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells. Eur J Immunol (2002) 0.94

Incidence of venereal warts in human immunodeficiency virus-infected and uninfected women. J Infect Dis (1995) 0.93

Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasia. J Gen Virol (1996) 0.92

Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide. J Gen Virol (1997) 0.92

HLA-A2-restricted peripheral blood cytolytic T lymphocyte response to HPV type 16 proteins E6 and E7 from patients with neoplastic cervical lesions. Cancer Immunol Immunother (1996) 0.92

Proliferative T-cell responses to human papillomavirus type 16 E5 are decreased amongst women with high-grade neoplasia. J Gen Virol (1998) 0.91

Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific. J Gen Virol (1994) 0.91

Definition of immunogenic determinants of the human papillomavirus type 16 nucleoprotein E7. Eur J Cancer (1992) 0.91

HIV, sexually transmitted diseases and gynaecologic disorders in women: increased risk for genital herpes and warts among HIV-infected prostitutes in Amsterdam. AIDS (1995) 0.90

Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals. J Gen Virol (1996) 0.90

Human T cell responses to human papillomavirus type 16 L1 and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction and virus type specificity. J Gen Virol (1990) 0.90

Induction of specific CD8+ T-lymphocyte responses using a human papillomavirus-16 E6/E7 fusion protein and autologous dendritic cells. Cancer Res (1999) 0.90

Epitope specificity and longevity of a vaccine-induced human T cell response against HPV18. Int Immunol (2004) 0.89

Lymphoproliferative response to fusion proteins of human papillomaviruses in patients with cervical intraepithelial neoplasia. Epidemiol Infect (1989) 0.87

CD4-positive and CD8-positive cytotoxic T lymphocytes contribute to human papillomavirus type 16 E6 and E7 responses. Clin Diagn Lab Immunol (1999) 0.86

Is HIV infection a risk factor for advanced cervical cancer? J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.85

T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection. J Gen Virol (1996) 0.83

Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: implications for cervical cancer immunotherapy. J Immunother (2000) 0.82

Identification of a cytotoxic T-lymphocyte epitope in the human papillomavirus type 16 E2 protein. J Gen Virol (1997) 0.81

Analysis of IgG reactivity against Human Papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study. Int J Cancer (1996) 0.81

Generation of tumor-specific cytotoxic T lymphocytes by stimulation with HPV type 16 E7 peptide-pulsed dendritic cells: an approach to immunotherapy of cervical cancer. Gynecol Oncol (1999) 0.81

HPV16-specific cytotoxic T lymphocyte responses are detected in all HPV16-positive cervical cancer patients. Gynecol Oncol (2005) 0.81

Presence of antibodies to human papillomavirus virus-like particles (VLPs) in 11-13-year-old schoolgirls. J Med Virol (1998) 0.80

Serological and T-helper cell responses to human papillomavirus type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls. J Gen Virol (1997) 0.79

Detection of CD4(+)- and CD8(+)-T-cell responses to human papillomavirus type 1 antigens expressed at various stages of the virus life cycle by using an enzyme-linked immunospot assay of gamma interferon release. J Virol (2002) 0.79

Human T cell responses to HPV 16 E2 generated with monocyte-derived dendritic cells. Int J Cancer (2001) 0.78

"Natural" presentation of human papillomavirus type-16 E7 protein to immunocompetent mice results in antigen-specific sensitization or sustained unresponsiveness. Eur J Immunol (1994) 0.77

Articles by these authors

(truncated to the top 100)

Using the Saccharomyces Genome Database (SGD) for analysis of protein similarities and structure. Nucleic Acids Res (1999) 13.65

Mapping of adenovirus 2 RNA sequences in lytically infected cells and transformed cell lines. Cold Spring Harb Symp Quant Biol (1975) 4.87

HR 756, a highly active cephalosporin: comparison with cefazolin and carbenicillin. Antimicrob Agents Chemother (1978) 4.74

Viral DNA in transformed cells. II. A study of the sequences of adenovirus 2 DNA IN NINE LINES OF TRANSFORMED RAT CELLS USING SPECIFIC FRAGMENTS OF THE VIRAL GENOME;. J Mol Biol (1974) 4.39

Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill (2009) 4.23

Do formal advance directives affect resuscitation decisions and the use of resources for seriously ill patients? SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Clin Ethics (1994) 4.23

Transcriptional elongation by RNA polymerase II is stimulated by transactivators. Cell (1994) 3.15

Depletion and disruption of dietary fibre. Effects on satiety, plasma-glucose, and serum-insulin. Lancet (1977) 3.08

Migration and stopover in a small pelagic seabird, the Manx shearwater Puffinus puffinus: insights from machine learning. Proc Biol Sci (2009) 3.03

The role of radiotracer imaging in Parkinson disease. Neurology (2005) 3.02

In a minority of gay men, sexual risk practice indicates strategic positioning for perceived risk reduction rather than unbridled sex. AIDS Care (2002) 3.01

Comparison of viral RNA sequences in adenovirus 2-transformed and lytically infected cells. J Mol Biol (1975) 2.95

Synthesis and characterization of phosphorescent cyclometalated iridium complexes. Inorg Chem (2001) 2.94

Multiple functional domains of human transcription factor IIB: distinct interactions with two general transcription factors and RNA polymerase II. Genes Dev (1993) 2.87

Correlation between tumor induction and the large external transformation sensitive protein on the cell surface. Proc Natl Acad Sci U S A (1976) 2.76

Expanding yeast knowledge online. Yeast (1998) 2.76

A foreign beta-globin gene in transgenic mice: integration at abnormal chromosomal positions and expression in inappropriate tissues. Cell (1983) 2.73

Frozen shoulder: a long-term prospective study. Ann Rheum Dis (1984) 2.67

Highly phosphorescent bis-cyclometalated iridium complexes: synthesis, photophysical characterization, and use in organic light emitting diodes. J Am Chem Soc (2001) 2.61

Frozen shoulder: prospective clinical study with an evaluation of three treatment regimens. Ann Rheum Dis (1984) 2.60

Isolation of an internal clock. J Exp Psychol Anim Behav Process (1981) 2.46

Situs revisited: imaging of the heterotaxy syndrome. Radiographics (1999) 2.33

Large DNA restriction fragment polymorphism in the Mycobacterium avium-M. intracellulare complex: a potential epidemiologic tool. J Clin Microbiol (1993) 2.25

Identification of the human papilloma virus-1a E4 gene products. EMBO J (1986) 2.21

Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med (1997) 2.20

Response to Mudford, Hogg, and Roberts on continuous recording of behavior state. Am J Ment Retard (1998) 2.19

Short answer questions in an undergraduate qualifying examination: a study of examiner variability. Med Educ (1984) 2.15

Activation of a Qa/Tla class I major histocompatibility antigen gene is a general feature of oncogenesis in the mouse. Nature (1984) 2.13

The sqt-1 gene of C. elegans encodes a collagen critical for organismal morphogenesis. Cell (1988) 2.11

Explicit and implicit neural mechanisms for processing of social information from facial expressions: a functional magnetic resonance imaging study. Hum Brain Mapp (2000) 2.04

Assessment of enzyme immunoassay and immunofluorescence tests for detection of Chlamydia trachomatis. J Clin Microbiol (1987) 2.03

Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a. J Virol (1987) 2.01

An improved banding technique exemplified in the karyotype analysis of two strains of rat. Chromosoma (1973) 2.01

Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res (2001) 1.95

Transcripts regulated during normal embryonic development and oncogenic transformation share a repetitive element. Cell (1983) 1.94

Comparison of EUS-guided 19-gauge Trucut needle biopsy with EUS-guided fine-needle aspiration. Endoscopy (2004) 1.87

The quality of routinely collected maternity data. Br J Obstet Gynaecol (1994) 1.85

Cortical rotation of the Xenopus egg: consequences for the anteroposterior pattern of embryonic dorsal development. Development (1989) 1.84

Developmental and transformation-sensitive expression of the Sparc gene on mouse chromosome 11. EMBO J (1986) 1.83

A fragment of the SV40 large T-antigen gene transforms. Nature (1982) 1.82

The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13. Osteoarthritis Cartilage (2008) 1.81

Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. Gastroenterology (1996) 1.76

The severity of alcohol dependence questionnaire: its use, reliability and validity. Br J Addict (1983) 1.76

Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system. Nat Biotechnol (1998) 1.75

Hard times--hard choices: positive decision-making for part-time women doctors. Med Educ (1987) 1.68

Methamphetamine and time estimation. J Exp Psychol Anim Behav Process (1981) 1.65

Difficulty in diagnosing double-chambered right ventricle in adults. Am J Cardiol (2001) 1.64

Single-nucleotide polymorphism (SNP) discovery and applications of SNP genotyping in nonmodel organisms. Mol Ecol Resour (2011) 1.63

A comparison of autoanalyser methods for the estimation of glucose in blood. Clin Chim Acta (1973) 1.63

Functional wrist motion: a biomechanical study. J Hand Surg Am (1985) 1.63

The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest (1997) 1.62

Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience (2000) 1.61

Gene regulation in the magnocellular hypothalamo-neurohypophysial system. Physiol Rev (2001) 1.61

Laparoscopic management of generalized peritonitis due to perforated colonic diverticula. Am J Surg (1996) 1.60

In vitro traits of adenovirus-transformed cell lines and their relevance to tumorigenicity in nude mice. Cell (1977) 1.60

Efficient and rapid affinity purification of proteins using recombinant fusion proteases. Biotechnology (N Y) (1994) 1.60

Cognitive and behavioral precursors of schizophrenia. Dev Psychopathol (1999) 1.60

Human immunodeficiency virus 1. Predominance of a group-specific neutralizing epitope that persists despite genetic variation. J Exp Med (1989) 1.59

A dual-centre, cohort comparison of open, laparoscopic and robotic-assisted radical cystectomy. Int J Clin Pract (2012) 1.58

Videoconferencing can be used to assess neonatal resuscitation skills. Med Educ (2001) 1.57

Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine. Ann Rheum Dis (1980) 1.57

Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors (1995) 1.56

Bacterial contamination of home nebuliser. Br Med J (Clin Res Ed) (1987) 1.55

Cell cluster formation in degenerate lumbar intervertebral discs is associated with increased disc cell proliferation. Connect Tissue Res (2001) 1.55

The assignment of chain specificities for anti-Ia monoclonal antibodies using L cell transfectants. J Immunol (1986) 1.54

Thirty years on: examination performance and career success of the 1950-1 intake of Cambridge medical students. Br Med J (Clin Res Ed) (1983) 1.54

Binge eating disorder in extreme obesity. Int J Obes Relat Metab Disord (2002) 1.53

Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage. Virology (1992) 1.53

Effect of antiretroviral treatment and counselling on disclosure of HIV-serostatus in Johannesburg, South Africa. AIDS Care (2006) 1.52

Robotic assisted radical cystectomy: short to medium-term oncologic and functional outcomes. Int J Clin Pract (2008) 1.52

Stimulation of actin stress fibre formation mediated by activation of phospholipase D. Curr Biol (1996) 1.51

Ovarian carcinoma presenting with inguinal metastatic lymphadenopathy 33 months prior to intraabdominal disease. Gynecol Oncol (1993) 1.50

Pathogenicity of cyathostome infection. Vet Parasitol (1999) 1.47

Interns as teachers of medical students: a pilot programme. Ir J Med Sci (2010) 1.46

Impaired ability of schizophrenics, relative to manics or depressives, to appreciate social knowledge about their culture. Br J Psychiatry (1990) 1.46

Guidelines for transesophageal echocardiography in children. J Am Soc Echocardiogr (1993) 1.45

Dehydration-induced proteome changes in the rat hypothalamo-neurohypophyseal system. Endocrinology (2007) 1.45

Intra-operative parathyroid hormone monitoring in secondary hyperparathyroidism: is it useful? Clin Otolaryngol (2006) 1.44

Molecular and functional heterogeneity of cholangiocytes from rat liver after bile duct ligation. Am J Physiol (1997) 1.44

Urinary 17-hydroxycorticosteroids measured by gas-liquid chromatography. J Endocrinol (1966) 1.44

Short course intravenous benzylpenicillin treatment of adults with meningococcal disease. Intern Med J (2004) 1.43

Analysis of antigen-specific, Ig-restricted cell-free material made by I-J+ Ly-1 cells (Ly-1 TsiF) that induces Ly-2+ cells to express suppressive activity. Eur J Immunol (1981) 1.42

Enhanced expression of p53 in human cells infected with mutant adenoviruses. Virology (1994) 1.42

Epithelioid angiosarcoma of the orbit presenting as Tolosa-Hunt syndrome. A clinicopathologic case report with review of the literature. Ophthalmology (1983) 1.39

Long-term follow-up of children after repair of atrial septal defects. Cleve Clin J Med (1994) 1.39

Long-term biomedical and psychosocial outcomes following DAFNE (Dose Adjustment For Normal Eating) structured education to promote intensive insulin therapy in adults with sub-optimally controlled Type 1 diabetes. Diabetes Res Clin Pract (2010) 1.38

Characterisation of cytoplasm-filled processes in cells of the intervertebral disc. J Anat (1998) 1.38

Psychiatric disorders in Parkinson's disease. Br J Hosp Med (1992) 1.38

Amplification and rearrangement of integrated SV40 DNA sequences accompany the selection of anchorage-independent transformed mouse cells. Cell (1980) 1.38

Chronic debilitating fatigue in Irish general practice: a survey of general practitioners' experience. Br J Gen Pract (1997) 1.34

Combined test of anterior pituitary function in children. Arch Dis Child (1978) 1.34

Carcinoembryonic antigen in the urine of patients with urothelial carcinoma. Br Med J (1972) 1.34

Analysis of an antigen-specific H-2-restricted cell-free products(s) made by "I-J-" Ly-2 cells (Ly-2 TsF) that suppresses Ly-2 cell-depleted spleen cell activity. Eur J Immunol (1981) 1.34

Matrix metalloproteinases in the human intervertebral disc: role in disc degeneration and scoliosis. Spine (Phila Pa 1976) (1997) 1.34

Interactions of adenovirus type 2 with rat embryo cells. Permissiveness, transformation and in vitro characteristics of adenovirus transformed rat embryo cells. J Gen Virol (1974) 1.33

Frequency of recent retrotransposition events in the human factor IX gene. Hum Mutat (2001) 1.33

Gender differences among medical students in attitudes to learning about complementary and alternative medicine. Complement Ther Med (2006) 1.33

High resolution MRI of the brain at 4.7 Tesla using fast spin echo imaging. Br J Radiol (2003) 1.32

Detection of the large external transformation-sensitive protein on some epithelial cells. Exp Cell Res (1977) 1.31

Hospital admission and mortality rates for venous thromboembolism in Oxford region, UK, 1975-98. Lancet (2000) 1.28